Standard BioTools's total assets for Q2 2025 were $556.97M, a decrease of -3.90% from the previous quarter. LAB total liabilities were $132.43M for the fiscal quarter, a 5.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.